Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Skinvisible's revenue for the twelve months ending Jun 30, 2026 was $20.00K, up 0.0% year over year. For fiscal 2025 it was $20.00K, up 0.0% from the year before. Over ten years it grew -19.5% a year on average. The highest annual figure on record is $663.43K in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.00K | 0.0% |
| FY2024 | Dec 31, 2024 | $20.00K | 0.0% |
| FY2023 | Dec 31, 2023 | $20.00K | -92.8% |
| FY2022 | Dec 31, 2022 | $279.30K | -57.9% |
| FY2021 | Dec 31, 2021 | $663.43K | +334.7% |
| FY2020 | Dec 31, 2020 | $152.63K | +262.8% |
| FY2019 | Dec 31, 2019 | $42.07K | -39.3% |
| FY2018 | Dec 31, 2018 | $69.35K | -89.0% |
| FY2017 | Dec 31, 2017 | $629.03K | +477.7% |
| FY2016 | Dec 31, 2016 | $108.89K | -37.6% |
| FY2015 | Dec 31, 2015 | $174.64K | +218.0% |
| FY2014 | Dec 31, 2014 | $54.92K | -17.7% |
| FY2013 | Dec 31, 2013 | $66.70K | -75.3% |
| FY2012 | Dec 31, 2012 | $270.30K | +50.0% |
| FY2011 | Dec 31, 2011 | $180.19K | -21.4% |
| FY2010 | Dec 31, 2010 | $229.18K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.00K | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.00K | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | $5.00K | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | $5.00K | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.00K | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | $5.00K | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $5.00K | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $5.00K | 0.0% |
| Q2 FY2024 | Jun 30, 2024 | $5.00K | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | $5.00K | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.00K | 0.0% |
| Q3 FY2023 | Sep 30, 2023 | $5.00K | -46.3% |
| Q2 FY2023 | Jun 30, 2023 | $5.00K | -98.0% |
| Q1 FY2023 | Mar 31, 2023 | $5.00K | -95.5% |
| Q4 FY2022 | Dec 31, 2022 | $5.00K | -98.3% |
| Q3 FY2022 | Sep 30, 2022 | $9.32K | -22.7% |
| Q4 FY2021 | Dec 31, 2021 | $252.86K | +93.0% |
| Q3 FY2021 | Sep 30, 2021 | $111.42K | +2563.7% |
| Q2 FY2021 | Jun 30, 2021 | $287.10K | +3090.0% |
| Q1 FY2021 | Mar 31, 2021 | $12.05K | -24.9% |
| Q4 FY2020 | Dec 31, 2020 | $131.04K | +1114.8% |
| Q3 FY2020 | Sep 30, 2020 | $4.18K | -63.0% |
| Q2 FY2020 | Jun 30, 2020 | $9.00K | -28.7% |
| Q1 FY2020 | Mar 31, 2020 | $16.05K | +91.8% |
| Q4 FY2019 | Dec 31, 2019 | $10.79K | -15.4% |
| Q3 FY2019 | Sep 30, 2019 | $11.30K | -39.5% |
| Q2 FY2019 | Jun 30, 2019 | $12.62K | -43.4% |
| Q1 FY2019 | Mar 31, 2019 | $8.37K | -46.5% |
| Q4 FY2018 | Dec 31, 2018 | $12.76K | -97.5% |
| Q3 FY2018 | Sep 30, 2018 | $18.68K | -69.6% |
| Q2 FY2018 | Jun 30, 2018 | $22.28K | -46.6% |
| Q1 FY2018 | Mar 31, 2018 | $15.63K | +24.9% |
| Q4 FY2017 | Dec 31, 2017 | $513.35K | +1902.8% |
| Q3 FY2017 | Sep 30, 2017 | $61.42K | +265.5% |
| Q2 FY2017 | Jun 30, 2017 | $41.74K | +9.5% |
| Q1 FY2017 | Mar 31, 2017 | $12.51K | – |
| Q4 FY2016 | Dec 31, 2016 | $25.63K | – |
| Q3 FY2016 | Sep 30, 2016 | $16.81K | – |
| Q2 FY2016 | Jun 30, 2016 | $38.11K | – |
See a number that looks wrong?